Attached files
| file | filename |
|---|---|
| EX-16.1 - Bohai Pharmaceuticals Group, Inc. | v227701_ex16-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): July 1, 2011 (June 24, 2011)
Bohai Pharmaceuticals Group, Inc.
(Exact name of registrant as specified in its charter)
|
Nevada
|
000-53401
|
98-0588402
|
||
|
(State or other jurisdiction
|
(Commission
|
(IRS Employer
|
||
|
of incorporation)
|
File Number)
|
Identification No.)
|
c/o Yantai Bohai Pharmaceuticals Group Co. Ltd.
No. 9 Daxin Road, Zhifu District
Yantai, Shandong Province, China 264000
(Address of principal executive offices)
Registrant’s telephone number, including area code: +86(535)-685-7928
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 4.01. Changes in Registrant's Certifying Accountants
On June 30, 2011, Bohai Pharmaceuticals Group, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Form 8-K”) regarding the dismissal of Parker Randall CF (H.K.) CPA Limited (“Parker Randall”) as the Company’s independent registered public accounting firm.
This amended Form 8-K is being filed to include a letter from Parker Randall, addressed to the Securities and Exchange Commission, stating that Parker Randall agrees with the statements made in the Form 8-K regarding their firm.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
16.1 Letter from Parker Randall CF (H.K.) CPA Limited dated July 1, 2011
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
July 1, 2011
|
Bohai Pharmaceuticals Group, Inc.
|
|
|
By:
|
/s/ Gene Hsiao
|
|
|
Name: Gene Hsiao
|
||
|
Title: Chief Financial Officer
|
||